HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José-Antonio Arias-Montaño Selected Research

Histamine (Histamine Dihydrochloride)

4/2016Pharmacoresistant temporal lobe epilepsy modifies histamine turnover and H3 receptor function in the human hippocampus and temporal neocortex.
9/2013A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H₃ receptor stably expressed in CHO-K1 cells.
3/2007Histamine augments beta2-adrenoceptor-induced cyclic AMP accumulation in human prostate cancer cells DU-145 independently of known histamine receptors.
10/2004Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José-Antonio Arias-Montaño Research Topics

Disease

5Parkinson Disease (Parkinson's Disease)
06/2023 - 10/2004
2Dyskinesias (Dyskinesia)
06/2023 - 06/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2020
2Neuroblastoma
04/2018 - 02/2018
1Obesity
10/2023
1Urinary Incontinence
10/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Diabetic Cardiomyopathies
10/2021
1Inflammation (Inflammations)
11/2020
1Schizophrenia (Dementia Praecox)
11/2020
1Medulloblastoma
01/2019
1Hypoxia (Hypoxemia)
01/2019
1Temporal Lobe Epilepsy
04/2016
1Migraine Disorders (Migraine)
09/2013
1Shy-Drager Syndrome
09/2013
1Prostatic Neoplasms (Prostate Cancer)
03/2007

Drug/Important Bio-Agent (IBA)

6Histamine H3 Receptors (Histamine H3 Receptor)IBA
06/2019 - 10/2004
5Dopamine (Intropin)FDA LinkGeneric
06/2023 - 01/2018
4Histamine (Histamine Dihydrochloride)FDA Link
04/2016 - 10/2004
3Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2016
2LigandsIBA
10/2023 - 01/2020
2gamma-Aminobutyric Acid (GABA)IBA
06/2023 - 06/2019
2Levodopa (L Dopa)FDA LinkGeneric
06/2023 - 06/2019
2Glutamic Acid (Glutamate)FDA Link
06/2023 - 06/2019
2Protein Isoforms (Isoforms)IBA
01/2022 - 04/2018
2Oxidopamine (6 Hydroxydopamine)IBA
06/2019 - 02/2018
2Amino AcidsFDA Link
04/2018 - 09/2013
1CholesterolIBA
10/2023
1Glucose (Dextrose)FDA LinkGeneric
10/2023
1Triglycerides (Triacylglycerol)IBA
10/2023
1Messenger RNA (mRNA)IBA
06/2023
1Presenilin-1IBA
01/2022
1Cathepsin DIBA
01/2022
1Phosphotransferases (Kinase)IBA
10/2021
1Protein Kinases (Protein Kinase)IBA
10/2021
1Adrenergic Agents (Adrenergic Drugs)IBA
10/2021
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
10/2021
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
10/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2020
1Particulate MatterIBA
11/2020
14-(1H-imidazol-4-ylmethyl)piperidineIBA
06/2019
1Dialysis SolutionsIBA
06/2019
1IfosfamideFDA LinkGeneric
01/2019
1EnzymesIBA
01/2019
1CytochromesIBA
01/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Cytochrome P-450 CYP3AIBA
01/2019
1Cytochrome P-450 CYP2B6 (CYP2B6)IBA
01/2019
1IonsIBA
04/2018
1ColforsinIBA
04/2018
1clobenpropitIBA
02/2018
1tele-methylhistamineIBA
04/2016
1Guanine NucleotidesIBA
04/2016
1Valine (L-Valine)FDA Link
09/2013
1Alanine (L-Alanine)FDA Link
09/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2012
1Histamine Receptors (Histamine Receptor)IBA
03/2007
1Cyclic AMP (AMP, Cyclic)IBA
03/2007
1AndrogensIBA
03/2007
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
03/2007
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2007

Therapy/Procedure

1Therapeutics
10/2023